α-SYNUCLEIN 2.0 – Moving towards Cell-Type Specific Pathophysiology.

α-SYNUCLEIN 2.0 – Moving towards Cell-Type Specific Pathophysiology.
α-SYNUCLEIN 2.0 - Moving towards Cell-Type Specific Pathophysiology. Neuroscience. 2019 Jun 13;: Authors: Thakur P, Chiu WH, Roeper J, Goldberg JA Abstract Since the landmark discovery that point mutations in the α-synuclein gene (SNCA) cause familial Parkinson's disease (PD) more than two decades ago, extensive research has been conducted to unravel the molecular and cellular mechanisms by which α-synuclein drives ... read more
Source: PubMedPublished on 2019-06-17